Search Results - "Wright, Gabriela M."

CDK4/6 inhibition synergizes with inhibition of P21-Activated Kinases (PAKs) in lung cancer cell lines by Wright, Gabriela M, Gimbrone, Nick T, Sarcar, Bhaswati, Percy, Trent R, Gordián, Edna R, Kinose, Fumi, Sumi, Natália J, Rix, Uwe, Cress, W. Douglas

“…Theoretically, small molecule CDK4/6 inhibitors (CDK4/6is) represent a logical therapeutic option in non-small cell lung cancers since most of these…”
Get full text

Role of Stat3 in Regulating p53 Expression and Function by Niu, Guilian, Wright, Kenneth L., Ma, Yihong, Wright, Gabriela M., Huang, Mei, Irby, Rosalyn, Briggs, Jon, Karras, James, Cress, W. Douglas, Pardoll, Drew, Jove, Richard, Chen, Jiangdong, Yu, Hua

“…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

CX3CR1 deficiency-induced TIL tumor restriction as a novel addition for CAR-T design in solid malignancies by Trinh, ThuLe, Adams, William A., Calescibetta, Alexandra, Tu, Nhan, Dalton, Robert, So, Tina, Wei, Max, Ward, Grace, Kostenko, Elena, Christiansen, Sean, Cen, Ling, McLemore, Amy, Reed, Kayla, Whitting, Junmin, Gilvary, Danielle, Blanco, Neale Lopez, Segura, Carlos Moran, Nguyen, Jonathan, Kandell, Wendy, Chen, Xianghong, Cheng, Pingyan, Wright, Gabriela M., Cress, W. Douglas, Liu, Jinghong, Wright, Kenneth L., Wei, Sheng, Eksioglu, Erika A.

“…Advances in the understanding of the tumor microenvironment have led to development of immunotherapeutic strategies, such as chimeric antigen receptor T cells…”
Get full text

CDKN1C Negatively Regulates RNA Polymerase II C-terminal Domain Phosphorylation in an E2F1-dependent Manner by Ma, Yihong, Chen, Lu, Wright, Gabriela M., Pillai, Smitha R., Chellappan, Srikumar P., Cress, W. Douglas

“…CDKN1C is a cyclin-dependent kinase inhibitor and is a candidate tumor suppressor gene. We previously found that the CDKN1C protein represses E2F1-driven…”
Get full text

CDK4/6 inhibition synergizes with inhibition of P21-Activated Kinases by Wright, Gabriela M, Gimbrone, Nick T, Sarcar, Bhaswati, Percy, Trent R, Gordián, Edna R, Kinose, Fumi, Sumi, Natália J, Rix, Uwe, Cress, W. Douglas

“…Theoretically, small molecule CDK4/6 inhibitors (CDK4/6is) represent a logical therapeutic option in non-small cell lung cancers since most of these…”
Get full text

Abstract 4454: Loss of CX3CL1 expression mediates immune evasion in STK11 mutated lung adenocarcinomas by Eksioglu, Eria, Wright, Gabriela M., Percy, Trent R., Wright, Kenneth L., Cress, W. Douglas

“…Abstract Immunotherapy has improved survival for many cancer patients, especially for immunogenic malignancies such as lung cancer. However, even in lung…”
Get full text

Abstract 5150: Improvement of hematopoiesis in primary low risk MDS with the TGFBR1 investigational inhibitor TP-6379 by Eksioglu, Erika A., Wright, Gabriela M., Foulks, Jason M., Lalonde, Matthew, Warner, Steven L., Wright, Kenneth L.

“…Abstract Background: The inflammaging modulator, S100A9, mediates immunosuppression and plays a key role in the pathogenesis of low-risk myelodysplastic…”
Get full text

CDKN1C (P57KIP2) NEGATIVELY REGULATES E2F1‐DRIVEN TRANSCRIPTION VIA A DIRECT INTERACTION by Cress, Doug, Wright, Gabriela M, Ma, Yihong

“…Abstract only Objective To determine the mechanism by which CDKN1C binds and transcriptionally represses E2F1‐driven transcription. We previously found that…”
Get full text